JP2024539520A5 - - Google Patents
Info
- Publication number
- JP2024539520A5 JP2024539520A5 JP2024548682A JP2024548682A JP2024539520A5 JP 2024539520 A5 JP2024539520 A5 JP 2024539520A5 JP 2024548682 A JP2024548682 A JP 2024548682A JP 2024548682 A JP2024548682 A JP 2024548682A JP 2024539520 A5 JP2024539520 A5 JP 2024539520A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- months
- immunogenic composition
- dose
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271420P | 2021-10-25 | 2021-10-25 | |
| US63/271,420 | 2021-10-25 | ||
| US202163281332P | 2021-11-19 | 2021-11-19 | |
| US63/281,332 | 2021-11-19 | ||
| PCT/US2022/078665 WO2023076907A1 (en) | 2021-10-25 | 2022-10-25 | Malaria vaccine formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539520A JP2024539520A (ja) | 2024-10-28 |
| JP2024539520A5 true JP2024539520A5 (cg-RX-API-DMAC7.html) | 2025-09-26 |
Family
ID=86158498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024548682A Pending JP2024539520A (ja) | 2021-10-25 | 2022-10-25 | マラリアワクチン製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240415947A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4422676A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024539520A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240099337A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022379612A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023076907A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2346523A4 (en) * | 2008-10-01 | 2014-12-31 | Us Health | MULTIPLE VACCINE VACCINATE AGAINST MALARIA TO CREATE LONG-TERM IMMUNE RESPONSE AGAINST PLASMODIA |
| WO2014111733A1 (en) * | 2013-01-21 | 2014-07-24 | Isis Innovation Limited | Composition and uses thereof |
| WO2019021013A1 (en) * | 2017-07-27 | 2019-01-31 | Oxford University Innovation Limited | ANTIMALARIAL VACCINE |
| AU2019410737A1 (en) * | 2018-12-21 | 2021-06-10 | CureVac SE | RNA for malaria vaccines |
-
2022
- 2022-10-25 US US18/704,632 patent/US20240415947A1/en active Pending
- 2022-10-25 WO PCT/US2022/078665 patent/WO2023076907A1/en not_active Ceased
- 2022-10-25 JP JP2024548682A patent/JP2024539520A/ja active Pending
- 2022-10-25 EP EP22888437.5A patent/EP4422676A4/en active Pending
- 2022-10-25 AU AU2022379612A patent/AU2022379612A1/en active Pending
- 2022-10-25 KR KR1020247017200A patent/KR20240099337A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8216595B2 (en) | Powerful vaccine composition comprising lipopeptide and poly I:C as an adjuvant | |
| CA2138997C (en) | Vaccine composition containing adjuvants | |
| US20080063649A1 (en) | Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response | |
| JP2016128513A5 (cg-RX-API-DMAC7.html) | ||
| EP0957933B1 (en) | Vaccine composition against malaria | |
| US11759517B2 (en) | Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virus | |
| JP2015524802A5 (cg-RX-API-DMAC7.html) | ||
| JP2011525169A (ja) | Toll様受容体3の選択的アゴニスト | |
| Hussein et al. | Nanotechnology-based vaccines | |
| JP2023012539A (ja) | 経鼻b型肝炎ワクチン組成物およびその製造方法 | |
| KR102292147B1 (ko) | 경구용 항바이러스제 및 리포펩타이드와 폴리(i:c) 아쥬반트를 포함한 치료백신을 유효성분으로 포함하는 만성 b형 간염의 예방 또는 치료용 약제학적 조성물, 약제학적 병용제제, 병용제 키트 | |
| CA1323302C (en) | Vaccine enhanced by interferon | |
| PH12020500194A1 (en) | Malaria vaccine | |
| Ranjha et al. | Rethinking malaria vaccines: perspectives on currently approved malaria vaccines in India’s path to elimination | |
| US7550150B2 (en) | Methods of treating or preventing a disease, disorder or condition associated with a viral infection | |
| EP2723374B1 (de) | Rekombinantes mistellektin und dessen verwendung als adjuvans | |
| CN106163554B (zh) | 一种包含pika佐剂的狂犬病组合物 | |
| EP4702988A1 (en) | Combination product for the treatment of leishmaniasis | |
| CN1270772C (zh) | 抗乙型肝炎病毒治疗性疫苗及其佐剂 | |
| WO2003026686A1 (en) | Potentiating the therapeutic effects of interferons | |
| IE914250A1 (en) | Use of interferon and a substance with an antimalarial¹activity for the treatment of malaria infections | |
| HK40092095B (en) | Pharmaceutical combined formulation for prevention or treatment of chronic hepatitis b, use thereof and combined formulation kit containing the same | |
| Mismetti et al. | Thromboprophylaxis in acute medical patients: need for an implementation strategy | |
| CN1424110A (zh) | 抗乙型肝炎病毒治疗性疫苗佐剂 |